Brahmi
Bacopa monnieri
200 mg per capsule · 400 mg at the 2-capsule serving
Human trials
A 2012 systematic review of six randomised controlled trials (300–450 mg/day of standardised extract, 12 weeks) found Bacopa improved performance on 9 of 17 memory free-recall measures. The reviewers noted little evidence of benefit in other cognitive domains and described the field as early. At our two-capsule serving the daily amount sits inside the range those trials used.
View published research on PubMed